Literature DB >> 19672072

Expression of MMP-12 after neonatal hypoxic-ischemic brain injury in mice.

Pernilla Svedin1, Henrik Hagberg, Carina Mallard.   

Abstract

Matrix metalloproteinase-12 (MMP-12) is expressed in the brain and is important for myelin formation in the developing brain, while MMP-12 deficiency protects against spinal cord injury in the adult, suggesting a role for MMP-12 after brain injury. However, the role of MMP-12 in neonatal hypoxic-ischemic brain injury is not known. The purpose of this study was to investigate the expression of MMP-12 in the brain after neonatal hypoxia-ischemia (HI). HI was induced by unilateral ligation of the left carotid artery followed by hypoxia (10% O(2), 36 degrees C) for 50 min in postnatal day 9 C57/Bl6J mice. At 24 and 72 h after HI, the mRNA and protein expression of MMP-12 were measured by real-time PCR and Western blot, respectively. Distribution and cellular expression of MMP-12 were examined by immunohistochemistry. At 72 h after HI, both MMP-12 mRNA and protein expression were significantly increased in the ipsilateral hemisphere compared to the contralateral hemisphere and sham-operated animals (p < 0.05). The extent of tissue loss in the ipsilateral hemisphere at 72 h after HI was positively correlated with the degree of MMP-12 protein expression (r = 0.900, p < 0.05). In nonischemic animals, immunohistochemical analysis demonstrated weak cytoplasmic MMP-12 immunoreactivity throughout the brain in cells which resembled neurons and stronger immunoreactivity was observed in blood vessels. After HI, the MMP-12 staining became more prominent in the ipsilateral hemisphere and immunohistochemical double-labeling experiments identified the MMP-12-positive cells as neurons, isolectin and Olig2-positive cells. This study demonstrates that MMP-12 is upregulated after HI, suggesting that MMP-12 may contribute to injury in the immature brain, similar to that seen in the adult. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672072     DOI: 10.1159/000232561

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  10 in total

Review 1.  MMP-12, a Promising Therapeutic Target for Neurological Diseases.

Authors:  Bharath Chelluboina; Koteswara Rao Nalamolu; Jeffrey D Klopfenstein; David M Pinson; David Z Wang; Raghu Vemuganti; Krishna Kumar Veeravalli
Journal:  Mol Neurobiol       Date:  2017-02-02       Impact factor: 5.590

2.  Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function.

Authors:  L A Pasquini; V Millet; H C Hoyos; J P Giannoni; D O Croci; M Marder; F T Liu; G A Rabinovich; J M Pasquini
Journal:  Cell Death Differ       Date:  2011-05-13       Impact factor: 15.828

3.  Enhanced expression of matrix metalloproteinase-12 contributes to Npc1 deficiency-induced axonal degeneration.

Authors:  Guanghong Liao; Zhuangjun Wang; Erik Lee; Stephanie Moreno; Omar Abuelnasr; Michel Baudry; Xiaoning Bi
Journal:  Exp Neurol       Date:  2015-04-09       Impact factor: 5.330

4.  Vancomycin Is Protective in a Neonatal Mouse Model of Staphylococcus epidermidis-Potentiated Hypoxic-Ischemic Brain Injury.

Authors:  Jacqueline C Y Lai; Pernilla Svedin; C Joakim Ek; Amin Mottahedin; Xiaoyang Wang; Ofer Levy; Andrew Currie; Tobias Strunk; Carina Mallard
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 5.  Does inflammation after stroke affect the developing brain differently than adult brain?

Authors:  Zinaida S Vexler; Midori A Yenari
Journal:  Dev Neurosci       Date:  2009-08-11       Impact factor: 2.984

6.  Therapeutic efficacy of matrix metalloproteinase-12 suppression on neurological recovery after ischemic stroke: Optimal treatment timing and duration.

Authors:  Siva Reddy Challa; Koteswara Rao Nalamolu; Casimir A Fornal; Billy C Wang; Ryan C Martin; Elsa A Olson; Ammar L Ujjainwala; David M Pinson; Jeffrey D Klopfenstein; Krishna Kumar Veeravalli
Journal:  Front Neurosci       Date:  2022-10-04       Impact factor: 5.152

Review 7.  Regulation and involvement of matrix metalloproteinases in vascular diseases.

Authors:  Matthew Amin; Sathnur Pushpakumar; Nino Muradashvili; Sourav Kundu; Suresh C Tyagi; Utpal Sen
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01

8.  Systemic stimulation of TLR2 impairs neonatal mouse brain development.

Authors:  Xiaonan Du; Bobbi Fleiss; Hongfu Li; Barbara D'angelo; Yanyan Sun; Changlian Zhu; Henrik Hagberg; Ofer Levy; Carina Mallard; Xiaoyang Wang
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

9.  Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage.

Authors:  Bharath Chelluboina; Aditi Warhekar; Matt Dillard; Jeffrey D Klopfenstein; David M Pinson; David Z Wang; Krishna Kumar Veeravalli
Journal:  Sci Rep       Date:  2015-05-08       Impact factor: 4.379

10.  A Hydroxypyrone-Based Inhibitor of Metalloproteinase-12 Displays Neuroprotective Properties in Both Status Epilepticus and Optic Nerve Crush Animal Models.

Authors:  Jonathan Vinet; Anna-Maria Costa; Manuel Salinas-Navarro; Giuseppina Leo; Lieve Moons; Lutgarde Arckens; Giuseppe Biagini
Journal:  Int J Mol Sci       Date:  2018-07-25       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.